Biotech Special: Computational Drug Discovery with Patrick Finneran

Biotech Special: Computational Drug Discovery with Patrick Finneran

Proteins are nanomachines inside cells and perform the incredible array of tasks required for cells to function. They are composed of a chain of hundreds to thousands of amino acid “building blocks”. Peptides are similar to proteins, but have only about 3 to 30 amino acids. Their smaller size gives them distinct properties that are useful in therapeutic applications.

Menten AI is using cutting-edge generative methods to engineer new peptide therapeutics, and are backed by Y Combinator, Khosla Ventures, and others.

Patrick Finneran is the Associate Director of Biochemistry at Menten. He joins the show to tell us about the drug development process, handling noisy biological data, building a hybrid team of software engineers and biologists, and more.

Sean’s been an academic, startup founder, and Googler. He has published works covering a wide range of topics from information visualization to quantum computing. Currently, Sean is Head of Marketing and Developer Relations at Skyflow and host of the podcast Partially Redacted, a podcast about privacy and security engineering. You can connect with Sean on Twitter @seanfalconer .

Please click here to see the transcript of this episode.

Sponsorship inquiries: sponsor@softwareengineeringdaily.com


Watch the video episode here:

SED

Software Engineering Daily covers software engineering, technology, and the broader forces shaping the industry. Since 2015, we have brought our audience in-depth conversations and reporting from the people who build and shape technology.

Thanks to our sponsors

This episode is brought to you by: